Biden highlights efforts to lower inhaler costs

  • Oops!
    Something went wrong.
    Please try again later.

WASHINGTON (NEXSTAR) – Starting soon, asthma sufferers will see the cost of their inhalers capped at just over $30 a month.

It’s an effort President Joe Biden is highlighting at the White House Wednesday as part of his plan to lower healthcare costs.

Three major drug manufacturers announced price limit for inhalers.

Back in January, lawmakers criticized major drug manufacturers for selling their asthma inhalers at significantly higher prices in the U.S. than other countries.

For example, one of AstraZeneca’s inhalers cost $645 in the U.S.  but just $49 in the U.K.

Since then, three of those four manufacturers, including AstraZeneca, say they’ll now cap the out-of-pocket cost for their inhalers at just $35 a month.

The White House says that decision is a major win for roughly 27 million Americans suffering from asthma which includes around four million children.

Lowering healthcare costs is a major part of the president’s re-election effort.

The president will also push to expand the number of drugs Medicare can negotiate prices for with pharmaceutical companies from ten to fifty.

“We must use all of our tools to make sure that Americans get access to the affordable health care that they deserve even when it means taking on powerful corporations,” said FTC chair Lina Khan.

The president is also expected to highlight the benefits from the inflation reduction act that was passed two years ago.

For the latest news, weather, sports, and streaming video, head to DC News Now | Washington, DC.